Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge

Biochemical and Biophysical Research Communications

Volumn 408, Issue 4, 2011, Pages 615-619

  Takahara, Yusuke ^a,b   Matsuoka, Saori ^b   Kuwano, Tetsuya ^a   Tsukamoto, Tetsuo ^a   Yamamoto, Hiroyuki ^b   Ishii, Hiroshi ^a,b   Nakasone, Tadashi ^b   Takeda, Akiko ^b   Inoue, Makoto ^c   Iida, Akihiro ^c   Hara, Hiroto ^c   Shu, Tsugumine ^c   Hasegawa, Mamoru ^c   Sakawaki, Hiromi ^d   Horiike, Mariko ^d   Miura, Tomoyuki ^d   Igarashi, Tatsuhiko ^d   Naruse, Taeko K ^e   Kimura, Akinori ^e   Matano, Tetsuro ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c DNAVEC Corporation   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

AIDS vaccine; CTL; HIV; Immunodominance; SIV

Indexed keywords

DNA VACCINE; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ACUTE PHASE RESPONSE; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA IMMUNIZATION; HAPLOTYPE; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS GENOME; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS VACCINES; ANIMALS; ANTIGENS, VIRAL; HUMANS; MACACA MULATTA; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC;

ANIMALIA; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 79956204440     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.04.071     Document Type: Article

References (23)

1. Koup R.A., Safrit J.T., Cao Y., Andrews C.A., McLeod G., Borkowsky W., Farthing C., Ho D.D. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 1994, 68:4650-4655.
2. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 1994, 68:6103-6110.
3. Matano T., Shibata R., Siemon C., Connors M., Lane H.C., Martin M.A. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J. Virol. 1998, 72:164-169.
4. Jin X., Bauer D.E., Tuttleton S.E., Lewin S., Gettie A., Blanchard J., Irwin C.E., Safrit J.T., Mittler J., Weinberger L., Kostrikis L.G., Zhang L., Perelson A.S., Ho D.D. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 1999, 189:991-998.
5. Goulder P.J., Watkins D.I. HIV and SIV CTL escape: implications for vaccine design. Nat. Rev. Immunol. 2004, 4:630-640.
6. Matano T., Kano M., Nakamura H., Takeda A., Nagai Y. Rapid appearance of secondary immune responses and protection from acute CD4 depletion after a highly pathogenic immunodeficiency virus challenge in macaques vaccinated with a DNA prime/Sendai virus vector boost regimen. J. Virol. 2001, 75:11891-11896.
7. Matano T., Kobayashi M., Igarashi H., Takeda A., Nakamura H., Kano M., Sugimoto C., Mori K., Iida A., Hirata T., Hasegawa M., Yuasa T., Miyazawa M., Takahashi Y., Yasunami M., Kimura A., O'Connor D.H., Watkins D.I., Nagai Y. Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial. J. Exp. Med. 2004, 199:1709-1718.
8. Takahashi-Tanaka Y., Yasunami M., Naruse T., Hinohara K., Matano T., Mori K., Miysazawa M., Honda M., Yasutomi Y., Nagai Y., Kimura A. Reference strand-mediated conformation analysis (RSCA)-based typing of multiple alleles in the rhesus macaque MHC class I Mamu-A and Mamu-B loci. Electrophoresis 2007, 28:918-924.
9. Kawada M., Tsukamoto T., Yamamoto H., Iwamoto N., Kurihara K., Takeda A., Moriya C., Takeuchi H., Akari H., Matano T. Gag-specific cytotoxic T lymphocyte-based control of primary simian immunodeficiency virus replication in a vaccine trial. J. Virol. 2008, 82:10199-10206.
10. + T-Cell help on control of a simian immunodeficiency virus challenge in rhesus macaques. J. Virol. 2009, 83:9339-9346.
11. Yamamoto H., Kawada M., Takeda A., Igarashi H., Matano T. Post-infection immunodeficiency virus control by neutralizing antibodies. PLoS ONE 2007, 2:e540.
12. Shibata R., Maldarelli F., Siemon C., Matano T., Parta M., Miller G., Fredrickson T., Martin M.A. Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques: determinants of high virus loads and CD4 cell killing. J. Infect. Dis. 1997, 176:362-373.
13. Li H.O., Zhu Y.F., Asakawa M., Kuma H., Hirata T., Ueda Y., Lee Y.S., Fukumura M., Iida A., Kato A., Nagai Y., Hasegawa M. A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression. J. Virol. 2000, 74:6564-6569.
14. Takeda A., Igarashi H., Nakamura H., Kano M., Iida A., Hirata T., Hasegawa M., Nagai Y., Matano T. Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model. J. Virol. 2003, 77:9710-9715.
15. Kestler H.W., Ringler D.J., Mori K., Panicali D.L., Sehgal P.K., Daniel M.D., Desrosiers R.C. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991, 65:651-662.
16. Matano T., Kano M., Odawara T., Nakamura H., Takeda A., Mori K., Sato T., Nagai Y. Induction of protective immunity against pathogenic simian immunodeficiency virus by a foreign receptor-dependent replication of an engineered avirulent virus. Vaccine 2000, 18:3310-3318.
17. Albritton L.M., Tweng L., Scadden D., Cunningham J.M. A putative murine retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 1989, 57:659-666.
18. + T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine. J. Virol. 2007, 81:5202-5211.
19. + cell responses in vaccine-based simian immunodeficiency virus controllers. AIDS 2010, 24:2777-2787.
20. Tenzer S., Wee E., Burgevin A., Stewart-Jones G., Friis L., Lamberth K., Chang C.H., Harndahl M., Weimershaus M., Gerstoft J., Akkad N., Klenerman P., Fugger L., Jones E.Y., McMichael A.J., Buus S., Schild H., van Endert P., Iversen A.K. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. Nat. Immunol. 2009, 10:636-646.
21. Goulder P.J.R., Watkins D.I. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat. Rev. Immunol. 2008, 8:619-630.
22. + T cells. J. Virol. 2009, 83:7641-7648.
23. Alexander L., Denekamp L., Czajak S., Desrosiers R.C. Suboptimal nucleotides in the infectious, pathogenic simian immunodeficiency virus clone SIVmac239. J. Virol. 2001, 75:4019-4022.